Literature DB >> 7550866

Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver.

H Watanabe1, H Ohira, M Kuroda, T Takagi, H Ishikawa, T Nishimaki, R Kasukawa, K Takahashi.   

Abstract

A 16-year-old boy was diagnosed as having primary sclerosing cholangitis (PSC), based on retrograde cholangiography showing mixed features of narrowing and dilatation of the common hepatic and intrahepatic bile ducts. However, periductal fibrosis was not observed in the needle biopsy liver specimen. The liver biopsy specimen obtained 11 years previously, at the onset of the disease had disclosed a marked infiltration of eosinophils in the portal tract with eosinophilic catinonic protein immunostaining, with marked eosinophilia (54%) being noted. In Japanese reports, eosinophilia of more than 7% was reported in 13 of 32 (40.6%) PSC patients. However, the early stage of PSC, with marked eosinophilia and eosinophilic infiltration in the liver, such as in the present case, has rarely been reported. The findings in this case suggest that eosinocytes are related to the pathogenesis of PSC.

Entities:  

Mesh:

Year:  1995        PMID: 7550866     DOI: 10.1007/bf02347572

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  9 in total

1.  PRIMARY SCLEROSING CHOLANGITIS.

Authors:  J G MANESIS; J F SULLIVAN
Journal:  Arch Intern Med       Date:  1965-02

2.  SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES.

Authors:  M P SMITH; R H LOE
Journal:  Am J Surg       Date:  1965-08       Impact factor: 2.565

3.  Primary sclerosing cholangitis; review and report of six cases.

Authors:  S I SCHWARTZ; W A DALE
Journal:  AMA Arch Surg       Date:  1958-09

4.  Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.

Authors:  A Foong; J V Scholes; G J Gleich; G M Kephart; P R Holt
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

5.  Secretory properties of eosinophils.

Authors:  B D Gomperts; O Cromwell
Journal:  Clin Exp Allergy       Date:  1991-01       Impact factor: 5.018

6.  Eosinophil cationic protein's role in human hepatic allograft rejection.

Authors:  P F Foster; A Bhattacharyya; H N Sankary; J Coleman; M Ashmann; J W Williams
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

7.  Association of primary sclerosing cholangitis with HLA-B8.

Authors:  R W Chapman; Z Varghese; R Gaul; G Patel; N Kokinon; S Sherlock
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

8.  Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study.

Authors:  S Terasaki; Y Nakanuma; M Yamazaki; M Unoura
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

9.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

Authors:  E J Clutterbuck; E M Hirst; C J Sanderson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

  9 in total
  9 in total

1.  A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.

Authors:  Isabelle Delèvaux; Marc André; Jacques Chipponi; Anne-Marie Milési-Lecat; P Déchelotte; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  Hepatobiliary disease associated with hypereosinophilia: a report of two patients and a review of the literature.

Authors:  L M Morgan-Rowe; M Pericleous; T V Luong; J S Dooley; A K Burroughs
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

3.  Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichiro Kato; Tadahiro Takada; Junichi Fukushima; Fukuo Kondo; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

Review 5.  Secondary sclerosing cholangitis in critically ill patients: current perspectives.

Authors:  Hafsteinn O Gudnason; Einar S Björnsson
Journal:  Clin Exp Gastroenterol       Date:  2017-06-23

6.  Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture.

Authors:  Dirk Walter; Sylvia Hartmann; Eva Herrmann; Jan Peveling-Oberhag; Wolf O Bechstein; Stefan Zeuzem; Martin-Leo Hansmann; Mireen Friedrich-Rust; Jörg G Albert
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

Review 7.  Review of primary sclerosing cholangitis with increased IgG4 levels.

Authors:  Charis D Manganis; Roger W Chapman; Emma L Culver
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

8.  Eosinophilic Cholangitis with Poor Prognosis after Corticosteroid- and Ursodeoxycholic Acid-Related Remission of Peripheral and Peribiliary Eosinophilia.

Authors:  Takahito Shimomura; Tomoki Nakajima; Toshiaki Nakashima; Yasutaka Morimoto; Junko Yamaoka; Akiko Shibuya; Tomoyuki Ohno; Norimasa Yoshida; Mitsuo Kishimoto; Eiichi Konishi; Hideo Tanaka; Michihisa Moriguchi; Yoshito Itoh
Journal:  Case Rep Gastroenterol       Date:  2021-02-18

9.  A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis.

Authors:  Hiroko Ikeda; Kazuyoshi Katayanagi; Hiroshi Kurumaya; Kenichi Harada; Yasunori Sato; Motoko Sasaki; Yasuni Nakanuma
Journal:  Gastroenterology Res       Date:  2011-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.